Temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: A broken promise?

Journal of Chemotherapy

Volumn 27, Issue 2, 2014, Pages 106-110

  Rizzo, Daniela ^a   Scalzone, Maria ^a   Ruggiero, Antonio ^a   Maurizi, Palma ^a   Attinà, Giorgio ^a   Mastrangelo, Stefano ^a   Lazzareschi, Ilaria ^a   Ridola, Vita ^a   Colosimo, Cesare ^a   Caldarelli, Massimo ^a   Balducci, Mario ^a   Riccardi, Riccardo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Children; Diffuse intrinsic pontine glioma; Temozolomide

Indexed keywords

COTRIMOXAZOLE; STEROID; TEMOZOLOMIDE; ALKYLATING AGENT; DACARBAZINE;

ADJUVANT CHEMORADIOTHERAPY; ADOLESCENT; ARTICLE; BACTERIAL INFECTION; CANCER PROGNOSIS; CHILD; CLINICAL ARTICLE; DRUG ACTIVITY; DRUG DOSE REDUCTION; FEMALE; GLIOMA; HUMAN; LEUKOPENIA; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; PROSPECTIVE STUDY; SKIN TOXICITY; THROMBOCYTOPENIA; ADJUVANT CHEMOTHERAPY; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; BRAIN STEM; BRAIN STEM NEOPLASMS; CANCER GRADING; DISEASE COURSE; DRUG EFFECTS; FOLLOW UP; ITALY; NERVE CELL; PATHOLOGY; PRESCHOOL CHILD; PRIVATE HOSPITAL; PROGNOSIS; RADIATION RESPONSE; SURVIVAL ANALYSIS; UNIVERSITY HOSPITAL;

ADOLESCENT; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN STEM; BRAIN STEM NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; DACARBAZINE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HOSPITALS, RELIGIOUS; HOSPITALS, UNIVERSITY; HUMANS; MALE; NEOPLASM GRADING; NEURONS; PROGNOSIS; PROSPECTIVE STUDIES; ROME; SURVIVAL ANALYSIS;

EID: 84923501738     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/1973947814Y.0000000228     Document Type: Article

References (26)

1. 1 Freeman CR, Farmer JP. Pediatric brain stem gliomas: a review. Int J Radiat Oncol Biol Phys. 1998;40(2):265-71
2. Qaddoumi I, Sultan I, Gajjar A. Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the surveillance, epidemiology, and end results database. Cancer. 2009;115(24):5761-70
3. Broniscer A, Gajjar A. Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist. Oncologist. 2004;9(2):197-206
4. Hargrave D, Bartels U, Bouffet E. Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol. 2006;7(3):241-8
5. Ruggiero A, Cefalo G, Garre´ ML, Massimino M, Colosimo C, Attina` G, et al. Phase II trial of temozolomide in children with recurrent high-grade glioma. J Neurooncol. 2006;77(1):89-94
6. Yung WK, Prados MD, Yaya-Tur R, Rosenfeld SS, Brada M, Friedman HS, et al. Multicenter Phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. J Clin Oncol. 1999;17(9):2762-71
7. Yung WK, Albright RE, Olson J, Fredericks R, Fink K, Prados MD, et al. A Phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer. 2000;83(5):588-93
8. Friedman HS, McLendon RE, Kerby T, Dugan M, Bigner SH, Henry AJ, et al. DNA mismatch repair and O6-alkylguanine- DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. J Clin Oncol. 1998;16(12): 3851-57
9. Gilbert MR, Friedman HS, Kuttesch JF, Prados MD, Olson JJ, Reaman GH, et al. A Phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy. Neurooncol. 2002;4(4):261-7
10. Stupp R, Dietrich PY, Ostermann Kraljevic S, Pica A, Maillard I, Maeder P, et al. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol. 2002;20(5):1375-82
11. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-96
12. Estlin EJ, Lashford L, Ablett S, Price L, Gowing R, Gholkar A, et al. Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children’s Cancer Study Group. Br J Cancer. 1998;78(5):652-61
13. Nicholson HS, Krailo M, Ames MM, Seibel NL, Reid JM, Liu- Mares W, et al. Phase I study of temozolomide in children and adolescents with recurrent solid tumors: a report from the Children’s Cancer Group. J Clin Oncol. 1998;16(9):3037-43
14. Available from: http://ctep.cancer.gov/forms/CTCAE.pdf
15. 15 Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53(282):457-81
16. Broniscer A, Iacono L, Chintagumpala M, Fouladi M, Wallace D, Bowers DC, et al. Role of temozolomide after radiotherapy for newly diagnosed diffuse brain stem glioma in children: results of a multiinstitutional study (SJHG-98). Cancer. 2005;103(1):133-9
17. Cohen KJ, Heideman RL, Zhou T, Holmes EJ, Lavey RS, Bouffet E, et al. Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children’s Oncology Group. Neuro Oncol. 2001;13(4):410-6
18. Chassot A, Canale S, Varlet P, Puget S, Roujeau T, Negretti L, et al. Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. J Neurooncol. 2012;106(2):399-407
19. Jalali R, Raut N, Arora B, Gupta T, Dutta D, Munshi A, et al. Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys. 2010;77(1):113-8
20. Chiang KL, Chang KP, Lee YY, Huang PI, Hsu TR, Chen YW, et al. Role of temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: experience at a single institution. Childs Nerv Syst. 2010;26(8):1035-41
21. Kebudi R, Cakir FB, Agaoglu FY, Gorgun O, Ayan I, Darendeliler E. Pediatric diffuse intrinsic pontine glioma patients from a single center. Childs Nerv Syst. 2013;29(4): 583-8
22. Freeman CR, Perilongo G. Chemotherapy for brain stem gliomas. Childs Nerv Syst. 1999;15(10):545-53
23. Donaldson S, Laningham F, Fisher PG. Advances toward an understanding of brainstem gliomas. J Clin Oncol. 2006;24(8):1266-72
24. Barrow J, Adamowicz-Brice M, Cartmill M, MacArthur D, Lowe J, Robson K, et al. Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas. NeuroOncology 2011;13(2):212-22
25. Zarghooni M, Bartels U, Lee E, Buczkowicz P, Morrison A, Huang A, et al. Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets. J Clin Oncol. 2010;28(8):1337-44
26. Faury D, Nantel A, Dunn SE, Guiot MC, Haque T, Hauser P, et al. Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors. J Clin Oncol. 2007;25(10):1196-208.